Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells

Basic fibroblast growth factor (bFGF) is a heparinbinding protein, expressing potent mitogenic and angiogenic properties. Elevated levels of bFGF have been identified in human gliomas and glioma cell lines, suggesting that bFGF expression is involved in the aberrant growth patterns associated with these tumors. In the present study, the influence of bFGF on additional parameters of glioma cell malignancy was evaluated utilizing three distinct methods to suppress bFGF expression or activity including antisense oligonucleotide primers, a neutralizing monoclonal antibody or an inhibitor of the agonist action of bFGF: (1) The addition of 30 μM bFGF‐specific antisense oligonucleotide primer to the human glioma cell line SNB‐19 resulted in a 55% inhibition in colony formation in soft agar. This effect was dose‐dependent and specific, as sense strand primer was ineffective in suppressing growth. In addition to exhibiting fewer colonies, antisense treatment significantly altered colony morphology. (2) SNB‐19 cell growth in culture was suppressed in the presence of a neutralizing bFGF‐specific monoclonal antibody. (3) Inositolhexakisphosphate, a newly identified antagonist of FGF binding and activity, suppressed SNB‐19 cell growth in soft agar culture. These results demonstrate that bFGF may regulate glioma growth and progression independent of its role in tumor angiogenesis and that bFGF release or secretion may be required for these actions. © 1993 Wiley‐Liss, Inc.

[1]  R. Maciunas,et al.  TGFβ1 and TGFβ2 are potential growth regulators for low‐grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesis , 1991 .

[2]  M. Jaye,et al.  Gene expression of fibroblast growth factor receptors in the tissues of human gliomas and meningiomas. , 1991, Biochemical and biophysical research communications.

[3]  S. Naber,et al.  Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. , 1991, Cancer research.

[4]  R. Morrison.  Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. , 1991, The Journal of biological chemistry.

[5]  D. Dexter,et al.  Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growth , 1990, Journal of neuroscience research.

[6]  A. Fontana,et al.  Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor / transforming growth factor (TGF)-β2 gene reveals striking differences to the TGF-β1 and -β3 genes , 1990 .

[7]  M. Jaye,et al.  Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Black,et al.  Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. , 1990, The Journal of clinical investigation.

[9]  R. Alterman,et al.  Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. , 1990, Cancer research.

[10]  P. Murphy,et al.  Messenger RNA stabilization accounts for elevated basic fibroblast growth factor transcript levels in a human astrocytoma cell line. , 1990, Molecular endocrinology.

[11]  G. Conn,et al.  Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Halaban,et al.  Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment , 1989, The Journal of cell biology.

[13]  P. Timmermans,et al.  Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. , 1989, Biochemical and biophysical research communications.

[14]  J. Cairncross,et al.  Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. , 1989, Journal of neurosurgery.

[15]  J. Rubin,et al.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. , 1989, Science.

[16]  D. Rifkin,et al.  Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.

[17]  D. Birnbaum,et al.  Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family. , 1989, Oncogene.

[18]  M. Goldfarb,et al.  The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors , 1988, Molecular and cellular biology.

[19]  J. Fiddes,et al.  Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein. , 1988, Oncogene.

[20]  T. Libermann,et al.  Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.

[21]  G. Peters,et al.  Multiple RNAs expressed from the int‐2 gene in mouse embryonal carcinoma cell lines encode a protein with homology to fibroblast growth factors. , 1988, The EMBO journal.

[22]  R. Mitchell,et al.  Expression of human basic fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth , 1988, The Journal of cell biology.

[23]  T. Kurokawa,et al.  Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA , 1988, Molecular and cellular biology.

[24]  F. Ali-Osman,et al.  Optimization and characterization of the capillary human tumor clonogenic cell assay. , 1988, Cancer research.

[25]  D. Dexter,et al.  Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. , 1988, Cancer research.

[26]  R. Weinberg,et al.  Basic fibroblast growth factor fused to a signal peptide transforms cells , 1988, Nature.

[27]  B. Haendler,et al.  Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family. , 1987, The EMBO journal.

[28]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Ittmann,et al.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family , 1987, Cell.

[30]  T. Libermann,et al.  An angiogenic growth factor is expressed in human glioma cells. , 1987, The EMBO journal.

[31]  K. Miyagawa,et al.  cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Fiddes,et al.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.

[33]  J. Fiddes,et al.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.

[34]  K. Zulch.  Brain tumors; their biology and pathology , 1986 .

[35]  W. Yung,et al.  Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells , 1986, Journal of cellular biochemistry.

[36]  C. Heldin,et al.  A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Libermann,et al.  Expression of epidermal growth factor receptors in human brain tumors. , 1984, Cancer research.

[38]  D. Schoenfeld,et al.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study , 1983, Cancer.

[39]  J. de Vellis,et al.  Growth of purified astrocytes in a chemically defined medium. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[41]  P. Kahn,et al.  Cellular tumorigenicity in nude mice. Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability , 1979, The Journal of cell biology.

[42]  R. H. Gray,et al.  Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. , 1978, Cancer research.

[43]  L. Fink,et al.  In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells. , 1976, Cancer research.

[44]  Richard B. Richter,et al.  Pathology of Tumors of the Nervous System. , 1964 .